PyInvesting

Market research

688389.SHG Shenzhen Lifotronic Technology Co., Ltd

SHG CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
5B
P/E ratio
31.79
Analyst target
13.915
Dividend yield
2.6%
Beta
0.37

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Shenzhen Lifotronic Technology Co., Ltd is currently in a long term uptrend where the price is trading 18.7% above its 200 day moving average.

From a valuation standpoint, the stock is 40.2% more expensive than other stocks from the None sector with a price to sales ratio of 17.4.

Shenzhen Lifotronic Technology Co., Ltd's total revenue rose by 30.4% to $161M since the same quarter in the previous year.

Its net income has increased by 48.1% to $51M since the same quarter in the previous year.

Based on the above factors, Shenzhen Lifotronic Technology Co., Ltd gets an overall score of 3/5.